Pak Fah Yeow International Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Pak Fah Yeow International Limited with three other
pharmaceutical manufacturers in North America:
Zogenix Incorporation
of UNITED STATES
(2020
sales of $13.64 million
of which 100%
was Pharmaceutical produc),
ProPhase Labs Inc
of UNITED STATES
($14.51 million
), and
Pulmatrix Inc
which is
also
based in UNITED STATES
($12.63 million
).
Sales Analysis.
During the second
quarter of 2021, sales at Pak Fah Yeow International Limited totalled
7.29 million Bermudian Dollars.
This is
an increase of 26.5%
from the 5.76 million Bermudian Dollars in sales at the company during the second quarter of 2020.
Pak Fah Yeow International Limited reported sales of 14.10 million Bermudian Dollars (US$14.10 million)
for the
year ending
December of 2020.
This
represents
a
sharp
decrease of 25.3%
versus 2019, when the company's sales were 18.86 million Bermudian Dollars.
Contributing to the drop in overall sales was the 71.5% decline
in Treasury Investment, from 127,905.30 Bermudian Dollars to 36,487.19 Bermudian Dollars.
There were also decreases in sales in
Healthcare (down 24.3% to 13.19 million Bermudian Dollars)
and
Property Investment (down 32.9% to 868,601.41 Bermudian Dollars)
.